Patents for C40B 30 - Methods of screening libraries (11,320)
11/2009
11/19/2009WO2009137921A1 Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy
11/19/2009US20090286695 Luminescent stem cells and uses thereof
11/19/2009US20090286694 Nucleic acid array with releaseable nucleic acid probes
11/19/2009US20090286693 Microarrays of tagged combinatorial triazine libraries
11/19/2009US20090286692 Cartridge and Method for Sample Analysis
11/19/2009US20090286691 Oligonucleotide for Detection of Bacteria Associated with Sepsis and Microarrays and Method for Detection of the Bacteria Using the Oligonucleotide
11/19/2009US20090286690 Modified Nucleic Acid Probes
11/19/2009US20090286689 Methods for analyzing differential gene expression associated with myeloproliferative disorders (mpd) cancer disease
11/19/2009US20090286282 Method for Producing Antibody Fragments
11/19/2009US20090285788 RANDOM RNAi LIBRARIES, METHODS OF GENERATING SAME, AND SCREENING METHODS UTILIZING SAME
11/19/2009CA2761571A1 Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy
11/19/2009CA2724583A1 High throughput methods of identifying neutral lipid synthases
11/19/2009CA2724475A1 Genetic alterations on chromosomes 21q, 6q and 15q and methods of use thereof for the diagnosis and treatment of type i diabetes
11/19/2009CA2724322A1 Diagnosis of melanoma and solar lentigo by nucleic acid analysis
11/19/2009CA2724231A1 Novel targets for regulation of angiogenesis
11/19/2009CA2723984A1 Predictors of patient response to treatment with egf receptor inhibitors
11/19/2009CA2723972A1 Tests to predict responsiveness of cancer patients to chemotherapy treatment options
11/19/2009CA2723296A1 Methods and systems for universal carrier screening
11/17/2009US7618788 Proteome epitope tags and methods of use thereof in protein modification analysis
11/12/2009US20090280999 Epitope-Captured Antibody Display
11/12/2009US20090280996 Delta 17 desaturase and its use in making polyunsaturated fatty acids
11/12/2009US20090280995 Method of diagnosis
11/12/2009US20090280994 Nucleic acid library or protein or peptide library
11/12/2009US20090280513 detecting bacterial infection by a polyglutamic acid- (PGA-) producing pathogen ; administration of a capsular polypeptide of a pathogen of interest and a CD40 agonist; immunization
11/12/2009US20090280478 Gene methylation and expression
11/12/2009US20090280137 Methods, Compositions, and Sequences of ZP-Binding Peptides for Immunocontraception of Dogs and Other Animals
11/12/2009US20090280110 Cell Model for Alzheimer's Disease Pathology
11/11/2009CN101578399A Compositions and methods for the inhibition of dishevelled proteins
11/11/2009CN100558948C Design method of composite sample store and its system
11/05/2009US20090275632 Methods of diagnosis and treatment
11/05/2009US20090275546 Diagnostic tests and personalized treatment regimes for cancer stem cells
11/05/2009US20090275484 Quantitative analysis of carbohydrate-protein interactions using glycan microarrays: determination of surface and solution dissociation constants
11/05/2009US20090275483 Quantitative microarray of intact glycolipid cd1d interaction and correlation with cell-based cytokine production
11/05/2009US20090275482 Normalization Probes for Comparative Genome Hybridization Arrays
11/05/2009US20090275481 Anchored Transferrin Fusion Protein Libraries
11/05/2009US20090275480 Universal readout for target identification using biological microarrays
11/05/2009US20090275130 Biomimetic nucleic acids
11/05/2009US20090275066 Immobilization of membrane porteins onto supports via an amphiphile
11/05/2009US20090275020 Traceability of Cellular Cycle Anomalies Targeting Oncology and Neurodegeneration
11/03/2009US7612019 Bioassay; membrane proteins; fusion proteins; capable of binding c-reactive protein; flow cytometry
11/03/2009CA2342767C Multihued labels
10/2009
10/29/2009WO2009132287A2 Libraries of genetic packages comprising novel hc cdr1, cdr2, and cdr3 and novel lc cdr1, cdr2, and cdr3 designs
10/29/2009WO2009132271A2 Risk stratification of genetic disease using scoring of amino acid residue conservation in protein families
10/29/2009WO2009131733A1 Gab2 amplification in melanoma
10/29/2009WO2009098450A3 Methods and compositions
10/29/2009US20090270480 Markers and Methods for Assessing and Treating Psoriasis and Related Disorders
10/29/2009US20090270423 Antibacterial small molecules and methods for their synthesis
10/29/2009US20090270277 Method for indexing nucleic acid sequences for computer based searching
10/29/2009US20090270275 Method and apparatus for scanning bio chips using light amplication by metal nano-particles
10/29/2009US20090270274 Biochips and related automated analyzers and methods
10/29/2009US20090270273 Array structures for nucleic acid detection
10/29/2009US20090270272 Assessing risk of disease progression in rheumatoid arthritis patients
10/29/2009US20090270271 3' Biased Detection of Nucleic Acids
10/29/2009US20090270270 Method for detecting intragenic large rearrangements
10/29/2009US20090270269 Nano-scale fluoro-biosensors exhibiting a low false alarm rate for rapid detection of biological contaminants
10/29/2009US20090270268 Methods for Obtaining Immortalized Antibody Secreting Cells
10/29/2009US20090270267 Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer
10/29/2009US20090270266 Method for Electrocatalytic Protein Detection
10/29/2009US20090270265 Molecular Characteristics of Non-Small Cell Lung Cancer
10/29/2009US20090269803 In Vivo Generation of Dna, Rna, Peptide, and Protein Libraries
10/29/2009US20090269342 Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
10/29/2009US20090269279 Toxicology and Cellular Effect of Manufactured Nanomaterials
10/27/2009CA2202154C Methods for drug screening
10/22/2009US20090265797 Novel Anti-IGF-IR Antibodies and Uses Thereof
10/22/2009US20090264317 Functionalized nanostructure, methods of manufacture thereof and articles comprising the same
10/22/2009US20090264311 Thermostable peroxide-driven cytochrome P450 oxygenase variants and methods of use
10/22/2009US20090264310 Screening method for the isolation of centrosomal cluster-inhibitors as anti-cancer agents
10/22/2009US20090264309 Methods for Screening for Compounds that Modulate Insulin Promoter Activity
10/22/2009US20090264308 biosensor solid substrate with integrated temperature control and a method to make the same
10/22/2009US20090264307 Array-based polymorphism mapping at single nucleotide resolution
10/22/2009US20090264306 Dna methylation biomarkers in lymphoid and hematopoietic malignancies
10/22/2009US20090264305 Polynucleotide Marker Genes and their Expression, for Diagnosis of Endotoxemia
10/22/2009US20090264304 Normalized nucleic acid libraries and methods of production thereof
10/22/2009US20090264303 Polypeptides having a functional domain of interest and methods of identifying and using same
10/22/2009US20090264302 Methods, systems and computer program products for determining treatment response biomarkers
10/22/2009US20090264301 Methods utilizing differential splicing events in blood cells for the detection of pathological events
10/22/2009US20090263875 Methods of generating protein variants with altered function
10/21/2009EP2110666A1 New method of detecting and analysing protein interactions in vivo
10/20/2009US7605175 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
10/20/2009US7604982 High-throughput screening method for intergrin antagonist and new peptide screened therefrom
10/15/2009WO2009124404A1 Methods of diagnosing acute cardiac allograft rejection
10/15/2009WO2009124403A1 Methods of diagnosing chronic cardiac allograft rejection
10/15/2009WO2009124396A1 Polymorphisms predictive of platinum-coordinating compound-induced ototoxicity
10/15/2009US20090260092 Methods of diagnosing alzheimer's disease and markers identified by set association
10/15/2009US20090258794 Apoptosis methods, genes and proteins
10/15/2009US20090258793 libraries of nucleic acid species each comprising a transcription unit having a promoter region operatively linked to a coding sequence; enable the indirect detection and analysis of particular biomolecules, for example, by mass spectrometry
10/15/2009US20090258792 Prostate Cancer Glycan Markers and Autoantibody Signatures
10/15/2009US20090258791 Fluid Based Analysis of Multiple Analytes by a Sensor Array
10/15/2009US20090258790 Identifying antigen clusters for monitoring a global state of an immune system
10/15/2009US20090258789 Methods of determining the prognosis of an adenocarcinoma
10/15/2009US20090258431 determination of activity, activation energy and product selectivity for the conversion of synthesis gas into hydrocarbons by using Fisher-Tropsch synthesis (FTS) catalysts in parallelized reaction spaces
10/15/2009US20090258037 Vaccine development strategy using microgravity conditions
10/15/2009US20090258013 Novel compositions and methods for the treatment of immune related diseases
10/15/2009CA2740950A1 Polymorphisms predictive of platinum-coordinating compound-induced ototoxicity
10/15/2009CA2721313A1 Method and apparatus for determining a probability of colorectal cancer in a subject
10/15/2009CA2720863A1 Methods of diagnosing acute cardiac allograft rejection
10/15/2009CA2720862A1 Methods of diagnosing chronic cardiac allograft rejection
10/14/2009EP1579908B1 The combinatorial synthesis of novel materials
10/14/2009CN101555630A Phage random peptide library of mycobacterium tuberculosis
10/13/2009CA2521846C Reverse-turn mimetics and method relating thereto
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 114